These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9184712)

  • 21. [Thrombocytopenia following a re-introduction of rifampicin in a daily treatment. Apropos of a case].
    Beji M; Louzir B; Ben Rhomdane N; Zouari M; Mtimet B; Daghfous J
    Tunis Med; 1995 May; 73(5):201-3. PubMed ID: 9507284
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
    Dekker TG; Lötter AP
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831
    [No Abstract]   [Full Text] [Related]  

  • 23. Ethambutol-induced pulmonary infiltrates with fever and skin rash: a case report.
    Chien HP; Huang ST; Yu MC; Wu IH; Lin TP
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jun; 61(6):371-4. PubMed ID: 9684516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fixed drug eruption after taking ethambutol].
    Bakayoko AS; Kaloga M; Kamagate M; Kone Z; Daix AT; Ohui E; Gbery I; Domoua K
    Rev Mal Respir; 2015 Jan; 32(1):48-51. PubMed ID: 25618204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fever and thin-walled cavitary lung lesions].
    Ramos A; Daza R; Alvarez-Espejo T; Guzmán MF
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):363-4. PubMed ID: 19419797
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of adverse drug reaction and predictivity of quality of life status in tuberculosis.
    Guo N; Marra F; Fitzgerald JM; Elwood RK; Marra CA
    Eur Respir J; 2010 Jul; 36(1):206-8. PubMed ID: 20595167
    [No Abstract]   [Full Text] [Related]  

  • 27. [Recommendations for the therapy of tuberculosis. (Position: December, 1988)].
    Merkel S; Fischer P; Weinecke W
    Z Erkr Atmungsorgane; 1989; 173(1):87-96. PubMed ID: 2800620
    [No Abstract]   [Full Text] [Related]  

  • 28. Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy.
    Lee BH; Koh WJ; Choi MS; Suh GY; Chung MP; Kim H; Kwon OJ
    Chest; 2005 Apr; 127(4):1304-11. PubMed ID: 15821209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antituberculous therapy-induced toxicity.
    Bharat A; Vedkumar M; Subhash HS; Abraham OC; Mathai D
    J Assoc Physicians India; 2003 May; 51():522-4. PubMed ID: 12974441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antituberculous therapy and acute liver failure.
    McKeon J; Patel AM
    Lancet; 1995 May; 345(8958):1170-1. PubMed ID: 7723556
    [No Abstract]   [Full Text] [Related]  

  • 31. A 32-year-old man with tuberculosis, fever, and rash.
    Story RE; Ditto AM
    Ann Allergy Asthma Immunol; 2004 May; 92(5):495-9. PubMed ID: 15191016
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug-induced hepatotoxicity of anti-tuberculosis drugs and their serum levels.
    Jeong I; Park JS; Cho YJ; Yoon HI; Song J; Lee CT; Lee JH
    J Korean Med Sci; 2015 Feb; 30(2):167-72. PubMed ID: 25653488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphocyte transformation test for the evaluation of adverse effects of antituberculous drugs.
    Schreiber J; Zissel G; Greinert U; Schlaak M; Müller-Quernheim J
    Eur J Med Res; 1999 Feb; 4(2):67-71. PubMed ID: 10066642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic approach in a case of allergic reaction to antituberculosis drugs -- a case report].
    Costin M; Tesloianu A; Mihăescu T; Butnaru E
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):487-9. PubMed ID: 23077942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cutaneous reaction after pyrazinamide initiation].
    Mulliez P; Mbassi Fouda FL; Roy Saint-Georges F
    Med Mal Infect; 2011 Sep; 41(9):499-500. PubMed ID: 21458177
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute liver failure in a pediatric patient with disseminated tuberculosis.
    Whitney J; Hurwitz M; Mojtahed A; Hwang C; Gallo A
    Dig Dis Sci; 2011 Oct; 56(10):2780-3. PubMed ID: 21695402
    [No Abstract]   [Full Text] [Related]  

  • 37. Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance.
    Reves R; Heilig CM; Tapy JM; Bozeman L; Kyle RP; Hamilton CD; Bock N; Narita M; Wing D; Hershfield E; Goldberg SV;
    Int J Tuberc Lung Dis; 2014 May; 18(5):571-80. PubMed ID: 24903795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of isoniazid-induced liver injury diagnosed by use of the DLST, and successful reintroduction of isoniazid for pleural tuberculosis.
    Ikegame S; Wakamatsu K; Fujita M; Nakanishi Y; Kajiki A
    J Infect Chemother; 2011 Aug; 17(4):530-3. PubMed ID: 21188445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrashort-course chemotherapy for culture-negative pulmonary tuberculosis--a qualified success.
    Cowie RL; Langton ME; Escreet BC
    S Afr Med J; 1985 Dec; 68(12):879-80. PubMed ID: 4071345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Desensitization therapy for allergic reactions of antituberculous drugs--evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis].
    Kobashi Y; Okimoto N; Matsushima T; Abe T; Nishimura K; Shishido S; Kawahara S; Shigeto E; Takeyama H; Kuraoka T
    Kekkaku; 2000 Dec; 75(12):699-704. PubMed ID: 11201137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.